ADVISORY, Feb. 12, 2013 (GLOBE NEWSWIRE) --
What:
Prothena [PRTA], a biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, will visit the NASDAQ MarketSite in Times Square.
